Novo Nordisk sues pharmacies over impure Wegovy, Ozempic dupes

A 0.25 mg injection pen of Novo Nordisk’s weight loss drug Wegovy is shown in this photo in Oslo, Norway, on Aug. 31, 2023. Victoria Klesty | Reuters Novo Nordisk on Thursday said it sued two compounding pharmacies in Florida for allegedly selling impure and “potentially unsafe” drugs claiming to contain semaglutide, the active ingredient … Read more

Weight loss drug Wegovy slashes risk of serious heart complications

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk | UCG | Getty Images Novo Nordisk’s Wegovy cut the risk of serious cardiovascular complications in people with obesity and heart disease in a closely … Read more

Oil deals ahead of Big Tech earnings

Omar Marques | Lightrocket | Getty Images This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see? You can subscribe here. What you need to know today Markets attempt comebackThe … Read more

Oil deals and awaiting tech earnings

Traders work on the floor of the New York Stock Exchange on April 26, 2023 in New York City.  Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where … Read more

Obesity medicine euphoria warning: Experts tackle ‘miracle drugs’

Two experts see major challenges facing the adoption of new obesity drugs. Dr. Kavita Patel, a physician and NBC News medical contributor, believes fresh data from Novo Nordisk on Ozempic’s ability to delay the progression of chronic kidney disease is among the strongest supporting evidence for secondary uses of the drug. However, she considers data … Read more

Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic

Novo Nordisk on Friday raised its outlook for its full-year sales and operating profit due to soaring demand for its blockbuster weight loss drug Wegovy and diabetes treatment Ozempic.  The revised forecast only confirms the frenzy for those weekly injections, which patients seek for their ability to help them lose significant weight over time. Ozempic … Read more

LVMH falls to 2023 low as growth slows, pulling luxury sector lower

A LVMH Moet Hennessy Louis Vuitton SE store in Shanghai, China on Wednesday, June 14, 2023. Bloomberg | Bloomberg | Getty Images Shares of LVMH dropped to their lowest level of the year on Wednesday morning, after the company reported a slowdown in revenue growth that was below expectations. The stock was down 6% at … Read more

Obesity pill data boosts Structure Therapeutics shares

Aykut Karahan | Istock | Getty Images Shares of Structure Therapeutics rose more than 30% on Friday after the biotech startup’s experimental obesity pill succeeded in a small early-stage trial.  The once-daily drug helped overweight or obese participants reduce up to 10 pounds of weight on average after four weeks of treatment, according to a … Read more

Novo Nordisk’s Wegovy weight reduction drug launches within the UK

Packages of the weight-loss drug Wegovy from the pharmaceutical firm Novo Nordisk lie on the gross sales counter in a Danish pharmacy. Stefan Trumpf | Image Alliance | Getty Photographs Novo Nordisk launched its Wegovy weight reduction injection within the U.Ok. on Monday, advancing the drug’s rollout in Europe regardless of ongoing provide constraints. The … Read more

Wegovy-maker Novo Nordisk extends curb on provide of weight-loss drug, raises outlook

A collection of injector pens for the Saxenda weight reduction drug are proven on this picture illustration in Chicago, Illinois, U.S., March 31, 2023.  Jim Vondruska | Reuters Novo Nordisk, which makes blockbuster drug Wegovy, raised its outlook for 2023 Thursday however stated it’s extending provide restrictions for some doses of the weight-loss drug. The Danish pharmaceutical firm … Read more